The value of maintaining cognition in patients with mild cognitive impairment: The innovation headroom and potential cost-effectiveness of roflumilast.
Alzheimer's & dementia : the journal of the Alzheimer's Association（2023）
摘要
The innovation headroom in MCI is substantial. Although the potential cost effectiveness of roflumilast treatment is uncertain, further research on its effect on dementia onset is likely valuable.
更多查看译文
关键词
Alzheimer's disease,cost effectiveness,decision-analytic modeling,dementia,economic evaluation,headroom,mild cognitive impairment,roflumilast,value of information
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要